The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
Latest news and blogs
News |
UK clinical trials performance improves but remains in intensive care
News |
Regulatory renewal needed for UK life sciences ambitions
Blog |
NHS England is taking welcome new steps to encourage clinical leaders to champion proven innovation in the NHS
News |
ABPI welcomes the Innovation Ecosystem Programme Review
2024 ABPI Code of Practice – new resources
The PMCPA has published new webinars and e-learning to aid understanding of the 2024 ABPI Code of Practice.
2024 ABPI Code of Practice
Copies of the 2024 ABPI Code are now available to order. Please note we are no longer delivering outside of the UK.
Partnering for progress: a data-driven analysis of NHS-industry partnerships
This world-first research aims to systematically measure how NHS-industry partnerships support improved patient outcomes using data from across the NHS.
Lives Lived Well
From patients and their loved ones to those working within the pharmaceutical industry in the UK, we share a common goal: Lives Lived Well.
Events
NICE Conference – 27 March 2025
Attend the NICE Conference on 27 March 2025, and save 10% on your ticket using the exclusive ABPI members discount code. Contact our team at membership team at membership@abpi.org.uk to get the code.
Save the date - ABPI Annual Conference 2025
ABPI’s flagship annual conference will be taking place in central London on 3 April 2025
UK clinical trials performance improves but remains in intensive care
A new report finds the UK’s global rankings for industry clinical trial delivery are improving but further challenges must be overcome.
Regulatory renewal needed for UK life sciences ambitions
A new report, 'Enhancing the role of UK medicine regulation' sets out key recommendations to rebuild the UK’s world-class reputation in regulatory science, medicines’ development and licensing.
Key facts and figures for the pharmaceutical industry in the UK
£46.7bn
Turnover [6]
£9bn
investment in UK R&D (more than UKRI’s entire annual budget) [3]
£17.6bn
direct Gross Value Added (GVA) [1]